Skip to content

The Survey Effect of Aromatherapy with Matricaria Chamomile Essential Oil on Anxiety and Hemodynamic Indices in patients with acute coronary syndrome.

The Survey Effect of Aromatherapy with Matricaria Chamomile Essential Oil on Anxiety and Hemodynamic Indices in patients with acute coronary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20080825001083N11
Enrollment
154
Registered
2020-09-06
Start date
2020-09-12
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome. Acute ischemic heart disease, unspecified

Interventions

Intervention 1: Intervention group: On the first day of men's and women's in the heart ward, the demographic profile form and the Spielberger Anxiety ?Questionnaire are completed through an interview

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Being Hospitalized in men and women heart wards in Booali Sina Teaching Hospital In Qazvin. Having a consciously written consent. The age range of 20 to 80 years. Having no history of cardiomyopathy, pulmonary, liver and Thyroid diseases, chronic headaches, migraine, Psychological, Anxiety or mental disorders, having any allergies and eczema, Alzheimer and Addiction. Do not taking Anti-anxiety and Anti-psychotic. Having no history of Sensitivity to Herbal ingredients and Aromatic Essential Oils. Having no history of Cardiopulmonary Resuscitation. Having no olfactory impairments. No deaths of relatives in the past month. Not doing any specific surgical or therapeutic procedures such as angiography on the day after the intervention. Full alertness. Having no history of Aromatherapy. Being able to understand and speak persian.

Exclusion criteria

Exclusion criteria: Lack of cooperation with the research team and showing reluctance to remain in the study during the investigation. Occurrence of any allergic reaction, pain, ?Dyspnea, dysrhythmia, sudden change in hemodynamic status during the intervention or death of the patient.

Design outcomes

Primary

MeasureTime frame
Anxiety. Timepoint: Before intervention, After intervention. Method of measurement: Spielberger Anxiety Questionnaire.;Systolic Blood Pressure. Timepoint: Before intervention, After intervention. Method of measurement: Alpk2 brand manual sphygmomanometer.;Dyastolic Blood Pressure. Timepoint: Before intervention, After intervention. Method of measurement: Alpk2 brand manual sphygmomanometer.;Pulse Rate. Timepoint: Before intervention, After intervention. Method of measurement: ESPRIT brand wrist watch.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Shafiei Kisoumi

Rasht University of Medical Sciences

Z.a.h.r.ashafiei431@gmail.com+98 13 3355 5058

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026